 |
|
Study Finds Blood Cells Can Be Reprogrammed to Act as Embryonic Stem Cells
April 21, 2009In a recent study, U.S. researchers have reprogrammed cells found in circulating blood into cells that are molecularly and functionally indistinguishable from embryonic stem cells, a revolutionary achievement that provides a readily accessible source of stem cells and an alternative to harvesting embryonic stem cells. The findings were prepublished online in Blood, the official journal of the American Society of Hematology.
Embryonic stem cells have long been coveted for their potential to treat a multitude of diseases as a result of their unique properties of nearly indefinite self-renewal and pluripotency (the ability to develop into any type of cell in the body), but their use has been the subject of political controversy.
"Our findings provide the first proof that cells from human blood can morph into stem cells," said senior study author George Q. Daley, MD, PhD, an investigator for the Howard Hughes Medical Institute at Children's Hospital, Boston. "Making pluripotent stem cells from blood, which is one of the easiest tissues to obtain, provides an easy strategy for generating patient-specific stem cells that are valuable research tools and may one day be used to treat a number of diseases."
To generate induced pluripotent stem cells (dubbed iPS cells), blood was collected from a 26-year-old male donor. From the blood sample, the researchers isolated CD34+ cells, a type of stem cell that produces only blood cells, and cultured them in growth factors for six days to increase their number.
During the culture, the scientists infected the CD34+ cells with viruses carrying reprogramming factors, genes normally expressed in embryonic stem cells that can reset the blood cells to an embryonic state. Colonies of cells exhibiting physical characteristics similar to embryonic stem (ES) cells appeared about two weeks after the procedure. To determine whether these cells were also functionally similar to ES cells, the scientists analyzed the CD34+ iPS cell lines to see if they had acquired stem cell "markers," the unique combination of proteins that coat the cells' surface and distinguish them from other types of cells. Indeed, the iPS cell lines expressed the same markers as ES cells and further shared the capacity to differentiate into a variety of specialized cell types.
In vitro, the iPS cells readily developed into clusters of cells called embryoid bodies from which cells of virtually any type can develop. These differentiated cells expressed genes for all three embryonic germ layers (the tissues from which all other tissue types in the body develop) and also produced myeloid and granulocyte colonies (types of white blood cells).
The group confirmed that the reprogrammed cells had acquired ES cell characteristics by injecting the newly reprogrammed cells into immunodeficient mice. The cells successfully generated well-differentiated teratomas, benign masses containing all three embryonic germ layers, including respiratory, bone, and neural tissue.
"Not only has this work identified a new programmable cell type, but the cells are easy to obtain and analyze in many research laboratories and bone marrow transplantation centers around the world," said Grover C. Bagby, MD, Professor of Medicine and Molecular and Medical Genetics at Oregon Health and Science University, who is not affiliated with the study. "These findings will immediately enhance the pace of laboratory research in this field and will ultimately help to determine whether iPS cells have a therapeutic potential equivalent to that of embryonic stem cells."
To receive a copy of the study, or to arrange an interview with the lead author, reporters may contact Patrick Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September 2008, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.
Blood, the official journal of ASH, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers weekly and is available in print and online at www.bloodjournal.org.
American Society of Hematology
To generate induced pluripotent stem cells (dubbed iPS cells), blood was collected from a 26-year-old male donor. From the blood sample, the researchers isolated CD34+ cells, a type of stem cell that produces only blood cells, and cultured them in growth factors for six days to increase their number.
During the culture, the scientists infected the CD34+ cells with viruses carrying reprogramming factors, genes normally expressed in embryonic stem cells that can reset the blood cells to an embryonic state. Colonies of cells exhibiting physical characteristics similar to embryonic stem (ES) cells appeared about two weeks after the procedure. To determine whether these cells were also functionally similar to ES cells, the scientists analyzed the CD34+ iPS cell lines to see if they had acquired stem cell "markers," the unique combination of proteins that coat the cells' surface and distinguish them from other types of cells. Indeed, the iPS cell lines expressed the same markers as ES cells and further shared the capacity to differentiate into a variety of specialized cell types.
In vitro, the iPS cells readily developed into clusters of cells called embryoid bodies from which cells of virtually any type can develop. These differentiated cells expressed genes for all three embryonic germ layers (the tissues from which all other tissue types in the body develop) and also produced myeloid and granulocyte colonies (types of white blood cells).
The group confirmed that the reprogrammed cells had acquired ES cell characteristics by injecting the newly reprogrammed cells into immunodeficient mice. The cells successfully generated well-differentiated teratomas, benign masses containing all three embryonic germ layers, including respiratory, bone, and neural tissue.
"Not only has this work identified a new programmable cell type, but the cells are easy to obtain and analyze in many research laboratories and bone marrow transplantation centers around the world," said Grover C. Bagby, MD, Professor of Medicine and Molecular and Medical Genetics at Oregon Health and Science University, who is not affiliated with the study. "These findings will immediately enhance the pace of laboratory research in this field and will ultimately help to determine whether iPS cells have a therapeutic potential equivalent to that of embryonic stem cells."
To receive a copy of the study, or to arrange an interview with the lead author, reporters may contact Patrick Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September 2008, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.
Blood, the official journal of ASH, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers weekly and is available in print and online at www.bloodjournal.org.
American Society of Hematology
Embryonic Stem Cell Current Events and Embryonic Stem Cell News RSSOf mice and men: Stem cells and ethical uncertainties
The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics.
Endocrine Society calls for expanded scope and funding for stem cell research
Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases.
Small mechanical forces have big impact on embryonic stem cells
Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers at the University of Illinois report. Applications for force-directed cell differentiation include therapeutic cloning and regenerative medicine.
Stem cell success points to way to regenerate parathyroid glands
An early laboratory success is taking University of Michigan researchers a step closer to parathyroid gland transplants that could one day prevent a currently untreatable form of bone loss associated with thyroid surgery.
NIH researchers identify key factor that stimulates brain cancer cells to spread
Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM).
Stem cell research: From molecular physiology to therapeutic applications
Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson's disease to paralysis.
Research may hold key to maintaining embryonic stem cells in lab
In a new study that could transform embryonic stem cell (ES cell) research, scientists at UT Southwestern Medical Center have discovered why mouse ES cells can be easily grown in a laboratory while other mammalian ES cells are difficult, if not impossible, to maintain.
Female human embryos adjust the balance of X chromosomes before implantation
Dutch researchers have found the first evidence that a process of inactivating the X chromosome during embryo development and implantation, which was known to occur in mice but unknown in humans, does, in fact, take place in human female embryos prior to implantation in the womb.
MU scientists convert pigs' connective tissue cells into stem cells
For years, proponents have touted the benefits of embryonic stem cell research, but the potential therapies still face hurdles.
What do blood stem cells need to grow? Blood flow
Blood stem cells literally go with the flow, according to a new report published as an immediate early publication in the journal Cell, a Cell Press journal, on May 13th.
More Embryonic Stem Cell Current Events and Embryonic Stem Cell News Articles
 |
Human Embryonic Stem Cell Protocols (Methods in Molecular Biology) by Kursad Turksen (Editor) Despite political and ethical controversies surrounding the study of human embryonic stem (hES) cells, new freedoms in regard to using them for research has allowed interest to remain high in understanding the regulatory mechanisms of stem cell self-renewal, their differentiation along various lineages, and their potential use in regenerative medicine. In Human Embryonic Stem Cell Protocols, Second Edition, internationally respected researchers expand upon the popular first edition and describe in detail their most useful techniques for the molecular and cellular manipulation of these intriguing cells. This diverse collection of readily reproducible methods has been optimized for the derivation, characterization, and differentiation of hES cells, with special attention given to... |
 |
Lines That Divide: The Great Stem Cell Debate Directed By: Brian Godawa Also With: Jack Hafer (Producer), Jennifer Lahl (Producer) With the Obama administration recently announcing its policy change on the issue of stem cell research and regenerative medicine, the questions surrounding this issue are increasingly more complex. This is why Lines That Divide: The Great Stem Cell Debate, a feature length documentary on stem cell research was made. Is stem cell research a potential miracle cure for diseases or a form of biological colonialism? The debate still rages over this controversial science. Supporters argue that it is our moral duty to pursue scientific progress that provides healing hope for humanity. Detractors argue that the ends don't justify the means in harvesting some human life to save others places our nations heart and soul on the same path as Germany in the late 1930's. This documentary seeks to... |
 |
The The Global Politics of Human Embryonic Stem Cell Science (Health Technology and Society Series) by Herbert Gottweis (Author), Brian Salter (Author), Catherine Waldby (Author) Features students and researchers in medical sociology, medicine and genetics, general politics of health, and comparative medical sociology. |
 |
The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics) by Suzanne Holland (Editor), Karen Lebacqz (Editor), Laurie Zoloth (Editor) Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, the limits of intervention into human cells and tissues, and the meaning of our corporeal existence. The fact that stem cells may be derived from living embryos that are destroyed in the process or from aborted fetuses ties the discussion of stem cell research to the ongoing debates on abortion. In... |
 |
Charlie Rose (August 9, 2001) In this rebroadcast of an hour that originally aired on May 4, 2001, a panel discusses their reactions to President Bush's announcement to allow limited federal funding for embryonic stem cell research. They are: Bill Kristol, Editor of The Weekly Standard Magazine, Senator Sam Brownback, Dr. Gerald Fischbach, Dean of the School of Medicine at Columbia University, Sharon Begley, senior editor at Newsweek Magazine, and Eric Pooley, an editor at Time Magazine. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Embryonic Stem Cell Protocols: Volume II: Differentiation Models (Methods in Molecular Biology) by Kursad Turksen (Editor) Now in two volumes, this completely updated and expanded edition of Embryonic Stem Cells: Methods and Protocols provides a diverse collection of readily reproducible cellular and molecular protocols for the manipulation of nonhuman embryonic stem cells. Volume two, Embryonic Stem Cell Protocols: Differentiation Models, Second Edition, covers state-of-the-art methods for deriving many types of differentiating cells from ES cells. The first volume, Embryonic Stem Cell Protocols: Isolation and Characterization, Second Edition, provides a diverse collection of readily reproducible cellular and molecular protocols for the isolation, maintenance, and characterization of embryonic stem cells. A companion CD provides electronic color versions of all illustrations in the book. Together, the two... |
 |
Charlie Rose with Gerald Fischbach, Silviu Itescu, Bill Futrell, Arlen Specter & Sam Brownback; Christopher Reeve (May 4, 2001) A panel on stem cell research featuring Dr. Gerald Fischbach, Dean of the Columbia Medical School, Dr. Silviu Itescu, Director of Transplantation Immunology at Columbia, Dr. Bill Futrell, President-Elect of the American Association of Plastic Surgeons, Pennsylvania Senator Arlen Specter and Kansas Senator Sam Brownback. They share their thoughts on the medical benefits that the use of stem cells will lead to and the ethical questions that are implicit in this medical procedure. Then, Christopher Reeve is on to give his opinion on the topic and encourages pushing ahead with research. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Differentiation of Embryonic Stem Cells, Volume 365 (Methods in Enzymology) by Author Unknown (Author) This volume covers all aspects of embryonic stem cell differentiation, including mouse embryonic stem cells, mouse embryonic germ cells, monkey and human embryonic stem cells, and gene discovery. * Early commitment steps and generation of chimeric mice * Differentiation to mesoderm derivatives * Gene discovery by manipulation of mouse embryonic stem cells |
 |
Embryonic Stem Cells: A Practical Approach (The Practical Approach Series) by Elena Notarianni (Editor), Martin J. Evans (Editor) The groundbreaking isolation of embryonic stem cells (or 'ES cells') of the mouse in the early 1980s triggered a sustained expansion of global research into their exploitation. This led to the routine genetic engineering of the mouse and revolutionised our understanding of biological processes in the context of the whole animal. ES cell biology remains a crucial and growing area of research with far-reaching implications for developmental and comparative biology as well as for human health. This book serves as a primer to ES cells, their derivation and experimental manipulation. It contains a broad compendium of methods of direct relevance to both graduate students and specialist researchers. An introductory chapter by the principle originator of ES cell research outlines the... |
 |
ABC News Nightline Henry's Story For every medical breakthrough, there are many more patients who undergo experimental treatment only to see it fail. But even though the treatment fails, the patient still plays an important role, and offers a generous gift to our overall understanding of science. Laurie Strongin and Allen Goldberg did not seek the role they played in medical research. They found themselves there unexpectedly in 1995 when their first born, Henry, was diagnosed with a rare and deadly disease called Fanconi Anemia. Immediately, they were thrust onto the frontlines of medical research. Before Henry was a toddler they found themselves in the middle of a debate that would soon grip the nation over embryonic tissue research. But for Laurie and Allen there was never a debate. Doctors told them that the best... |
| © 2009 BrightSurf.com |